Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Lyra Therapeutics (LYRA) Depreciation and Depletion (2021 - 2025)

Lyra Therapeutics has reported Depreciation and Depletion over the past 5 years, most recently at $59000.0 for Q4 2025.

  • Quarterly results put Depreciation and Depletion at $59000.0 for Q4 2025, down 65.5% from a year ago — trailing twelve months through Dec 2025 was $459000.0 (down 19.61% YoY), and the annual figure for FY2025 was $459000.0, down 2.55%.
  • Depreciation and Depletion for Q4 2025 was $59000.0 at Lyra Therapeutics, down from $100000.0 in the prior quarter.
  • Over the last five years, Depreciation and Depletion for LYRA hit a ceiling of $400000.0 in Q3 2021 and a floor of -$68000.0 in Q3 2023.
  • Median Depreciation and Depletion over the past 5 years was $185500.0 (2024), compared with a mean of $175650.0.
  • Biggest five-year swings in Depreciation and Depletion: plummeted 122.67% in 2023 and later skyrocketed 969.57% in 2024.
  • Lyra Therapeutics' Depreciation and Depletion stood at $278000.0 in 2021, then fell by 8.27% to $255000.0 in 2022, then tumbled by 58.04% to $107000.0 in 2023, then skyrocketed by 59.81% to $171000.0 in 2024, then crashed by 65.5% to $59000.0 in 2025.
  • The last three reported values for Depreciation and Depletion were $59000.0 (Q4 2025), $100000.0 (Q3 2025), and $200000.0 (Q2 2025) per Business Quant data.